Dr. Phil Bonomi, from Rush University, provides his view on the targeted therapy approaches most likely to become clinically useful in lung cancer over the next several years.
Dr. Phil Bonomi, from Rush University, provides his view on the targeted therapy approaches most likely to become clinically useful in lung cancer over the next several years.
leggi di più
leggi meno
10 anni fa
#advanced, #antipd1, #bonomi, #braf, #cancer, #cancergrace, #crizotinib, #grace, #gracecast, #immunotherapy, #lung, #magea3, #mutation, #nivolumab, #phil, #ros1, #rush, #university, #vemurafenib, #xalkori
